Abstract
443 - Efficacy of Tixagevimab-Cilgavimab in Preventing Sars-Cov-2 in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have